For in-vitro research only · Not for human use · 18+

New prices. Permanently 30% lower.Already marked down from original prices · No code needed
← Back to all articles

Selank peptide sequence and experimental models

October 30, 2026

Selank peptide identity

Selank is described in the molecular literature as the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro. A heptapeptide contains seven amino-acid residues; the sequence is an identity reference, distinct from any outcome measured in an experiment. The 2018 publication by Vyunova and colleagues describes this sequence while examining the peptide's molecular activity.

Receptor-binding experiments

The same publication reports radioligand-receptor methods involving GABA binding. Receptor-binding observations depend on the assay and experimental material used. A molecular research summary should identify the binding measurement without turning it into a general claim about the peptide in unrelated settings.

Sequence versus experimental endpoint

A peptide sequence answers which residues define the molecule. A receptor assay answers a narrower experimental question about binding under the study conditions. These are complementary records, but neither can substitute for the other: knowing a sequence does not predict every assay result, and a binding observation is not a complete chemical identity record.

The cited molecular study supplies Selank sequence and receptor-method context. It is not a study of a catalogue lot and does not establish effects outside the described experimental system. Keep model details, peptide identity and measured endpoint together when comparing this publication with another laboratory reference.

References

Vyunova et al. (2018): Molecular aspects of heptapeptide Selank biological activity

Materials in this catalogue are offered for in-vitro laboratory research only, not human or veterinary use. This reference does not provide dosing, preparation, storage or treatment instructions.

Check the listing identity

Read the compound name, labelled amount and any blend composition on the current product listing. An amount per vial is not a dose or a preparation protocol. Current prices and availability belong to the catalogue, not an older article.

Check a lot document, where published

A report is shown only if one has been published for that lot. Compare its identifiers with the listing and vial label. A missing report is not evidence of testing or quality.

Consult the appropriate source

For handling, consult the supplier safety data sheet and your institution's standard operating procedures. For regulatory questions, consult official TGA guidance; a research-use label does not determine legal status.

Research catalogue · Lot documents · Official guidance · Shipping details and carrier estimates · Contact

Related articles